ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Helius Medical Technologies, Inc. (HSDT) stock declined over -6.61%, trading at $0.41 on NASDAQ, down from the previous close of $0.44. The stock opened at $0.43, fluctuating between $0.41 and $0.42 in the recent session.
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Employees | 22 |
Beta | 1.63 |
Sales or Revenue | $644.00K |
5Y Sales Change% | -0.971% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |